Study of VVN001 Ophthalmic Solution in Dry Eye Disease
Status:
Active, not recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
This is a Phase 2a, multi-center, double-masked, randomized, vehicle-controlled,
parallel-group study designed to evaluate the safety and tolerability and to explore the
efficacy activity of VVN001 ophthalmic solution versus vehicle in subjects with dry eye
disease.